Non-Pulmonary Effects Induced by the Addition of Formoterol to Budesonide Therapy in Patients with Mild or Moderate Persistent Asthma

Publisher： Karger

E-ISSN： 1423-0356|67|1|60-64

ISSN： 0025-7931

Source： Respiration, Vol.67, Iss.1, 2000-02, pp. : 60-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

By Scicchitano R.   Aalbers R.   Ukena D.   Manjra A.   Fouquert L.   Centanni S.   Boulet L.-P.   Naya I.P.   Hultquist C.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1403-1418

Informa Healthcare

Access to resources Recommend Favorite

Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma

By Buhl R   Vogelmeier C  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1867-1878

Informa Healthcare

Access to resources Recommend Favorite

Budesonide/formoterol for maintenance and reliever therapy: new quality in asthma management

By Kuna Piotr   Kuprys-Lipinska Izabela  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 495-512

Future Medicine

Access to resources Recommend Favorite

Addition of Formoterol or Montelukast to Low-Dose Budesonide: An Efficacy Comparison in Short- and Long-Term Asthma Control

By  

Respiration, Vol. 71, Iss. 6, 2004-12 ,pp. : 594-601

Karger

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation

By  

Respiration, Vol. 91, Iss. 1, 2016-0 ,pp. : 9-17

Karger

Access to resources Recommend Favorite